A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant that manufactures it from Sanofi.
The biologics facility is located in Lynnwood, Washington, has been operational since 2012; the biotech revealed that the facility will become an integral part of the company’s manufacturing ability, as well as serving as a centre for its supply chain operations.
